IDEX Biometrics ASA
IDXAF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.10 | 6.19 | 2.69 |
| FCF Yield | -12,837.44% | -37.92% | -20.62% | -4.14% |
| EV / EBITDA | -0.13 | -0.25 | -5.06 | -21.44 |
| Quality | ||||
| ROIC | -253.13% | -112.01% | -128.50% | -82.54% |
| Gross Margin | -1,445.54% | 5.58% | 20.72% | 55.85% |
| Cash Conversion Ratio | 1.28 | 1.01 | 0.98 | 0.85 |
| Growth | ||||
| Revenue 3-Year CAGR | -42.10% | 13.50% | 55.18% | 161.79% |
| Free Cash Flow Growth | 35.85% | 15.02% | -16.51% | -16.84% |
| Safety | ||||
| Net Debt / EBITDA | -0.11 | 0.02 | 0.15 | 1.13 |
| Interest Coverage | -9.26 | -42.15 | -22.01 | -27.92 |
| Efficiency | ||||
| Inventory Turnover | 2.22 | 0.61 | 0.73 | 1.02 |
| Cash Conversion Cycle | 566.42 | 618.10 | 530.28 | 357.85 |